<DOC>
	<DOC>NCT01552187</DOC>
	<brief_summary>This is a multicenter, double-blind, randomized trial to assess the efficacy and safety of colchicine for post-pericardiotomy syndrome prevention, post-operative effusions prevention, and post-operative atrial fibrillation prevention.</brief_summary>
	<brief_title>COlchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 Trial)</brief_title>
	<detailed_description>This is a multi center, double-blind, randomized trial to test the efficacy and safety of colchicine for prevention of post-pericardiotomy syndrome, post-operative effusions, and post-operative atrial fibrillation.</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Pleural Effusion</mesh_term>
	<mesh_term>Pericardial Effusion</mesh_term>
	<mesh_term>Postpericardiotomy Syndrome</mesh_term>
	<mesh_term>Colchicine</mesh_term>
	<criteria>Age &gt; 18years Candidate to cardiac surgery but cardiac transplantation Informed consent Atrial fibrillation Candidate to cardiac transplantation Severe liver disease or elevation of serum transaminases (&gt; 1.5 times the upper reference limit) Serum creatinine &gt; 2.5 mg/dL Preoperative elevation of CK or known myopathy Known chronic intestinal diseases or blood dyscrasias Pregnancy, Lactation or Women of childbearing potential not protected by a contraception method Hypersensitivity to colchicine Treatment with colchicine for any cause</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>cardiac surgery</keyword>
	<keyword>post-pericardiotomy syndrome</keyword>
	<keyword>atrial fibrillation</keyword>
	<keyword>pericardial effusion</keyword>
	<keyword>pleural effusion</keyword>
	<keyword>prevention</keyword>
	<keyword>colchicine</keyword>
</DOC>